This is a reason to go long though. Presence in over 38 countries requires capital to increase treatment centers and train Doctors.
- Also, every time they have expanded in new markets, revenues rose. They rose by about 43% between 2021 - 2023.
- Insurers in the Uk and Spain are increasingly accepting OncoSil treatment so this momentum just needs to persist.
News: OSL Oncosil Medical Seeks Trading Halt, page-24
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(9.09%) |
Mkt cap ! $18.32M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.5¢ | $15.58K | 2.796M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 12085555 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 24100252 | 23 |
View Market Depth
| Last trade - 13.52pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
-0.001 ( 9.09 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 5000 | ||
| Last updated 10.20am 28/05/2024 ? | |||||
| OSL (ASX) Chart |